← Back to Search

Stem Cell Therapy

Human spinal cord stem cells. for Spinal Cord Injury (SCI Trial)

Phase 1
Waitlist Available
Led By Joseph Ciacci, MD
Research Sponsored by Neuralstem Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 60
Awards & highlights

SCI Trial Summary

This trial is testing a new treatment for spinal cord injury using stem cells.

Eligible Conditions
  • Spinal Cord Injury

SCI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 60
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 60 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adverse events and clinically significant laboratory abnormalities
Secondary outcome measures
Graft survival in the transplant site as determined by MRI (for Group A) and via autopsy, if one is completed.
Other outcome measures
EMG, SCIM, ISNC SCI, and Bowel and bladder follow-up

SCI Trial Design

1Treatment groups
Experimental Treatment
Group I: Surgical implantation of human spinal cord stem cellsExperimental Treatment1 Intervention
Surgical implantation of human spinal cord derived neural stem cells.

Find a Location

Who is running the clinical trial?

Neuralstem Inc.Lead Sponsor
6 Previous Clinical Trials
537 Total Patients Enrolled
Joseph Ciacci, MDPrincipal InvestigatorUCSD Medical Center, Division of Neurosurgery

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~1 spots leftby Apr 2025